Skip to content
Search AI Powered

Latest Stories

AIMP warns of ‘tsunami of further pharmacy closures’

AIMP warns of ‘tsunami of further pharmacy closures’

Fight4Pharmacies campaign launched, calling on the government to invest in community pharmacy.

The Association of Independent Multiple Pharmacies (AIMp) has raised concerns over the mounting pressure faced by general practitioners (GPs) in England due to the loss of community pharmacies.


According to the organisation, more than 400 local chemists have closed in five years, leading to 2.5 million more GP appointments and exacerbating the strain on already stretched GP surgeries.

AIMp CEO Dr Leyla Hannbeck pointed to a combination of “chronic underfunding, medicine supply challenges and a dysfunctional reimbursement system” as the catalyst behind the alarming surge in pharmacy closures.

She warned that if this trend persists, it could trigger a “tsunami of further pharmacy closures” across the country, as quoted by The Mirror.

Additionally, Dr. Leyla highlighted that the sector is grappling with a £1.2 billion funding deficit, resulting in pharmacies “falling into debt” and uncertainty about their sustainability.

According to AIMP, the previous five-year funding agreement (set in 2019 at £2.6 billion annually) failed to consider inflation. Consequently, this has resulted in a year-on-year real-term funding cut, leading to a £1.2 billion shortfall.

On Wednesday, AIMp launched its Fight4Pharmacies campaign, calling on the government to invest in community pharmacy.

‘No funds available to fund community pharmacies’

During a recent meeting with pharmacy minister Andrea Leadsom, Dr Hannbeck and AIMp board member Has Modi discussed the current challenges in the sector and offered solutions on how the community pharmacy network could support the NHS.

They highlighted to the minister that pharmacies could play a vital role in the prevention agenda and management of long-term conditions, but the current funding shortfall has left has left numerous pharmacies grappling to stay afloat.

Additionally, the minister was informed that the sector “is consistently seeing medicines prices go up and pharmacies are left out of pocket because the concessions are not granted on time and the system is flawed.”

However, Leadsom responded that “there are no funds available to fund community pharmacies”.

Referring to reports received by the government indicating that pharmacies like Boots and other large multiples are “making money,” she suggested that independents should also “strive to increase their retail offering and provide more private services.”

AIMp then outlined to the minister that “not all pharmacies can be compared to Boots.” They elaborated that over 90 per cent of the activities in independent pharmacies are NHS activities and many of these chemists are based in “areas of deprivation and health and inequality where the public cannot pay for private services or goods and expect NHS to cover the costs.”

However, the minister acknowledged that the price fluctuations have left contractors out of pocket and that this needs to be addressed on priority.

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less